08:00 - 09:30
Parallelsitzung I: Basic Science
Großer Saal / 1. Obergeschoss
Vorsitz: Theresa Hautz, Innsbruck; Moritz Muckenhuber, Wien
Impulsvortrag:
Extracorporal photopheresis (ECP): The science behind its immunomodulatory effects
James Hutchinson, Regensburg
Abstracts:
Impact of maintainance immunosuppressives and BH4 on macrophages
Katharina Lackner, Innsbruck
Donor-specific IgE increases donor-specific B cells and augments alloreactive T cell proliferation in a CD23-dependent manner
Anna Marianne Weijler, Wien
Perturbing the NAD salvage pathway as a new therapeutic target to combat acute allograft rejection
Bernhard Texler, Innsbruck
Targeting DSA-secreting bone marrow long-lived plasma cells with CTLA4-Ig
Moritz Muckenhuber, Wien
Gene Expression Analysis of B and T Cells in Lung Transplant Patients Receiving mTOR Inhibitor
Sharooz Nasrollahi Shirazi, Wien
Cytokine absorption during ex vivo liver perfusion potentially reduces cytokine levels and inflammation
Sabrina Stimmeder, Graz
Cytokine profiling in DBD and DCD livers during normothermic machine perfusion
Julia Hofmann, Innsbruck
08:00 - 09:30
Parallelsitzung II: Lunge
Kleiner Saal / 1. Obergeschoss
Vorsitz: Judith Löffler-Ragg, Innsbruck; Konrad Hoetzenecker, Wien
Impulsvorträge:
Medikamentöses Bridging zur LTx bei sekundärer PH
Judith Löffler-Ragg & Brigitte Bucher, Innsbruck
UAGs, HLAs und sensitisierte Empfänger
Peter Jaksch, Wien
Abstracts:
First Report of CD38 Antibody Daratumumab in Clinical Lung Transplantation
Caroline Hillebrand, Wien
Women as lung transplant patients - an immunological risk?
Daniela Koren, Wien
De Novo Donor-Specific Antibodies and early-onset Chronic Lung Allograft Dysfunction in Lung Transplantation
Sophia Auner, Wien
TTV guided belatacept conversion after lungtransplantation: Report of 7 cases
Peter Jaksch, Wien
First clinical experience with tixagevimab and cilgavimab in lung transplant recipients during Omicron wave
Zsofia Kovacs, Wien
08:00 - 09:30
Pflegesitzung 1: Transplantation interdisziplinär
Seminarraum / 1. Obergeschoss
Vorsitz: Christina Schlederer, Wien; Martina Bittermann, Wien
Atemtherapie auf der Intensivstation
Matthias Parzer-Lenz, Wien
Die Rolle der Ergotherapie auf der Intensivstation
Eva Gratzer, Wien
09:30 - 10:00
Kaffeepause & Besuch der Ausstellung
Foyer / 1. Obergeschoss
10:00 - 11:30
Plenum 1
Großer Saal / 1. Obergeschoss
Vorsitz: TBD
Sprecher TBD
10:00 - 11:30
Pflegesitzung 2: KMT
Seminarraum / 1. Obergeschoss
Vorsitz: Christoph Schmelz-Bräuer, Wien; Martina Bittermann, Wien
Knochenmarkstransplantation - News, Erfahrungen, Ausblicke und alt Bewährtes
Martina Spalt, Wien
Patrick Heindl, Wien
Claudia Eggenfellner, Wien
11:45 - 12:45
Lunch Symposium
(von Mallinckrodt organisiert)
Kleiner Saal / 1. Obergeschoss
11:45 - 12:45
Poster Walk
Großer Saal / 1. Obergeschoss
Moderatoren: TBD
NIERE:
Control of Torque Teno virus load by classical complement pathway –
results from a first-in-human phase I trial utilizing anti-C1s antibody sutimlimab
Markus Wahrmann, Wien
Double Kidney Transplantation: A Case Report and Review of the Literature
Manfred Kalteis, Linz
HLA specific antibodies - or rather not - A case report
Daniela Koren, Wien
Diagnostic accuracy of urinary C-X-C motif chemokine ligand (CXCL)9 in relation
to kidney allograft rejection and injury
Katharina Mayer, Wien
Evolving Landscape of Pediatric Kidney Transplantation: Analysis of Developments
and Outcomes over the last 15 years in Innsbruck
Madita Buch, Innsbruck
Robotic-assisted kidney transplantation – first experience in Austria
Jakob Eichelter, Wien
BASIC SCIENCE:
Innovative Organ Transport Method: Advanced Air Mobility
Robin Karpstein, Graz
The Enhancer Landscape Predetermines the Skeletal Regeneration Capacity of Stromal Cells
Sarah Hochmann, Salzburg
Deep immune phenotyping of iPSC-derived HLA-homozygous cardiomyocytes
Nicole Maeding, Salzburg
Comprehensive Characterization of Immune Cell Phenotypes in Lung Transplant
Patients Receiving Belatacept
Hatice Oya Akyildiz, Wien
Development of an Easy-to-Use Flow Cytometric Panel for Monitoring B
Regulatory Cells in Transplant Recipients
Hatice Oya Akyildiz, Wien
Nutritional supplements effects in combination with CTx in treating CRCLM. Rat model
Beatrice Lukenaite, Graz
Sub-normothermic liver machine perfusion: equal performance of Custodiol® and Belzer MPS®
Sabrina Stimmeder, Graz
Experimental Static Cold Storage of the Rat Uterus: Protective Effects of Relaxin-
or Erythropoietin-Supplemented HTK-N Solutions
Lina Jakubauskiene, Graz
HERZ:
Outcomes and 3-years of experience with CD38 antibody Daratumumab in sensitized
heart transplantation recipients
Clemens Atteneder, Wien
Psoas muscle area, an independent predictor for mortality in patients undergoing heart transplantation?
Tandis Aref, Wien
LUNGE:
Lung transplant in patients with suspicious lung nodules: A single-center retrospective data analysis
Merjem Begic, Wien
Lung Transplantation for Patients with a High-Risk Profile
Panja Böhm, Wien
First clinical experience with tixagevimab and cilgavimab in lung transplant
recipients during Omicron wave
Zsofia Kovacs, Wien
Persistent de novo DSA are associated with shorter CLAD-free survival
Sophia Auner, Wien
LEBER:
Viability assessment during hypothermic machine perfusion with combined
experimental biomarkers FMN and Syndecan-1'
Laurin Rauter, Wien
13:00 - 14:30
Plenum 2: Jungforscher Preise
Großer Saal / 1. Obergeschoss
Vorsitz: TBD
Klinisch:
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination
by TTV load in kidney transplant recipients and hemodialysis patients
Marianne Graninger, Wien
Mitochondrial flavin mononucleotide measured during hypothermic machine perfusion
can predict graft dysfunction after liver transplantation
Jule Dingfelder, Wien
Custodiol-N versus Custodiol: Results from a Prospective Randomized Single Blind,
Multicenter Phase III Trial in Patients Undergoing Heart Transplantation
Emilio Osorio-Jaramillo, Wien
6MWD as predictor for long term survival after lung transplantation in patients with ILD
Panja Böhm, Wien
Experimentell:
CD8+CD3- cells are critical for Treg mediated humoral tolerance
Romy Steiner, Wien
Adoptive cell transfer for allergen specific tolerance induction
Lisa Prickler, Wien
Perioperative IL-6 blockade promotes intra-graft regulation and prevents
costimulation-blockade resistant rejection
Moritz Muckenhuber, Wien
The complex interplay of T cell depletion with ATG and adoptive Treg transfer in mice
Anna Marianne Weijler, Wien
13:00 - 14:30
Pflegesitzung 3: Organperfusion
Seminarraum / 1. Obergeschoss
Vorsitz: Christoph Schmelz-Bräuer, Wien; Martina Bittermann, Wien
Leber
Jule Dingfelder, Wien
Lunge
Panja Böhm, Wien
Herz
Johann Horvat, Wien
14:30 - 15:00
Kaffeepause & Besuch der Ausstellung
Foyer / 1. Obergeschoss
15:00 - 16:30
Parallelsitzung I: Niere 1
Großer Saal / 1. Obergeschoss
Vorsitz: Gregor Bond, Wien; Annemarie Weißenbacher, Innsbruck
Impulsvortrag:
Novel insights into chronic allograft dysfunction
Anthony Dorling, London
Abstracts:
Predictive Validity of the Basel Assessment of Adherence to Immunosuppressive
Medication Scale (BAASIS©) After Renal Transplantation – A Prospective Cohort Study
Frederick Haupenthal, Wien
BK-Virus-specific IgG antibodies identify ABOi patients at high risk of BKPyV DNAemia
Michael Eder, Wien
The iBox score as a predictive factor in a retrospective kidney retransplant cohort
Annemarie Weißenbacher, Innsbruck
Impact of natural killer cell functional genetics on microvascular inflammation
in the presence of donor-specific antibodies
Matthias Diebold, Wien
15:00 - 16:30
Parallelsitzung II: Psychologie
Kleiner Saal / 1. Obergeschoss
Vorsitz: Bettina Gober, Wien; Daniel König-Castillo, Wien
Zwischen Selektion, Stigmatisierung und Versorgung: Aktuelle Standards zur Versorgung
von Patient:innen mit alkoholassoziierter Leberzirrhose und Indikation
zur Transplantation in Deutschland
Angela Buchholz, Hamburg
Das Integrated Care Mode - Endstageliverdisease und Alcoholusedisorder
Jolana Wagner-Skacel & Lukas Repnik, Graz
“Adherence – it takes more than a pillbox”
Katharina Ebenberger, Wien
Interkulturelle Herausforderungen in der Kommunikation im Organspende-Prozess
und die ÖBIG-Transplant Kommunikationsseminare
Sandra Ecker & Barbara Nepp, Wien
15:00- 16:30
Pflegesitzung 4: Ausblicke
Seminarraum / 1. Obergeschoss
Vorsitz: Christina Schlederer, Wien; Iris Bachtrögler-Krenn, Wien
Ausblicke für die Leberersatztherapie
David Pereyra, Wien
ÖBIG Pflegereferenten - Tätigkeit, Projekte und Zukunftsvisionen
Michaela Jelinek & Anita Entner, ÖBIG
16:45 - 18:15
Parallelsitzung I: Firmensymposium: Das kleine 1x1 des CMV-Managements – von einfach bis komplex
(von Takeda organisiert)
Großer Saal / 1. Obergeschoss
Vorsitz: Florian Thalhammer, Wien
CMV-Guidelines und komplexe Fälle: Wie vereinbar?
Farsad Eskandary, Wien
CMV in der Herztransplantation: Alle neu?
Andreas Zuckermann, Wien
Fallstricke in der CMV-Therapie
Florian Thalhammer, Wien
16:45 - 18:15
Parallelsitzung II: Stammzelltransplantation und Zelltherapie
(unterstützt durch Neovii)
Kleiner Saal / 1. Obergeschoss
Vorsitz: Nina Worel, Wien; Anita Lawitschka, Wien
Impulsvorträge:
CAR & SCT in ALL (ped and adult)
Christina Peters, Wien
CAR-T regulatory cells in solid organ transplantation
Thomas Wekerle, Wien
ECP for targeted immunomodulation in chronic GvHD
Hildegard Greinix, Graz
Cell-based regenerative therapies for broken hearts & bones & sore skin
Dirk Strunk, Salzburg
Abstracts (Poster Präsentationen im Sitzungssaal):
Impact of the recipients’ pre-treatment blood lymphocyte count on intended and unintended
effects of anti-T-lymphocyte globulin in allogeneic hematopoietic stem cell transplantation
Alexander Nikoloudis, Linz
Systemic Steroid Use and GVHD Adjudication During the First Year after Allogeneic HSCT
Julia Cserna, Wien
Protein corona of EVs is essential for skin cell self organization and aids wound healing
Martin Wolf, Salzburg
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed
lymphoma (BEB): a multicentre, randomised, phase II trial
Alexandra Böhm, Wien
Plerixafor vs placebo for stem cell mobilization in patients with multiple myeloma
optimizes collection results in moderate mobilizers (Optimize)
Andreas Tanzmann, Wien
Follow-Up-Care in SCT & CT
Felix Keil, Wien
Thymus-Transplantation
Herbert Pichler, Wien
18:15 - 18:45
ATX Generalversammlung
Seminarraum / 1. Obergeschoss
19:30 - 23:00
Award-Dinner & Networking
Schloss Esterhazy
Änderungen vorbehalten!